health
January 19, 2026
US big pharma sector poised to hike prices in Europe
US drugmakers are reportedly looking to maintain profits at the expense of Europeans to offset lower prices at home
TL;DR
- Major drugmakers are reportedly seeking ways to maintain profits amidst US efforts to lower drug costs.
- Donald Trump's initiative pressures big pharma to benchmark US medicine prices against other countries.
- 16 major global drug companies agreed to price cuts in exchange for tariff relief.
- Pfizer CEO Albert Bourla stated that ceasing supplies to countries like France is more incentivized than lowering US prices.
- Other executives are privately considering delaying or withdrawing new drugs in Europe.
- European countries have centralized healthcare systems that negotiate lower drug prices.
- The US system's lack of collective negotiation historically leads to higher prices.
- Pressure from the US could significantly impact European access to medicine.
Continue reading the original article